Clinical trial Recruiting at 2 sites Phase 2 Interventional Ages 18 and up

Corticosteroid versus saline injections for thumb osteoarthritis

Official title: Comparison of the Efficacy of Intra-Articular Corticosteroid Injections Versus Saline Solution for Thumb Osteoarthritis: Double-Blind Pragmatic Randomized Pilot Study

Run by Université du Québec à Trois-Rivières · NCT06401317 · Data updated 2026-11-12

This study will test whether saline injections work better than corticosteroid (triamcinolone) injections to reduce pain and improve hand function in adults with thumb (trapeziometacarpal) osteoarthritis.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversité du Québec à Trois-Rivières
Academic / other
Locations2 sites (Montreal, Quebec and 1 other locations)
StatusRecruiting
StartedNovember 4, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedAugust 18, 2026
Trial IDNCT06401317 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18) with X-ray‑confirmed trapeziometacarpal osteoarthritis who have pain at the base of the thumb, for whom the treating physician would consider an intra‑articular corticosteroid injection, and who can read English or French.

Probably not a fit

Patients with traumatic thumb pain, inflammatory arthritis (such as rheumatoid arthritis), prior corticosteroid injections within 12 months, prior surgery on the affected thumb, pregnancy or breastfeeding, or known allergy to any injection components are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a pragmatic, double-blind, randomized pilot trial that will enroll 40 adults with X-ray–confirmed trapeziometacarpal osteoarthritis to compare intra‑articular triamcinolone versus saline (0.9% NaCl) injections. Participants and the physicians performing injections will be blinded and randomized 1:1, with primary outcomes focused on pain reduction and hand function and secondary measures of feasibility. The pilot follows PRECIS-2 guidance and will collect data on recruitment, retention, and blinding success to inform a larger definitive trial. Study visits are conducted at CHUM sites in Montreal and materials are provided in French and English.

Why it matters

Potential benefit: If successful, saline injections could offer a cheaper and potentially safer alternative to corticosteroids for reducing pain and improving hand function in thumb osteoarthritis.

How similar studies have gone: Systematic reviews and prior randomized trials have shown mixed results but indicate that saline injections can sometimes relieve osteoarthritis pain and that corticosteroids do not consistently outperform placebo.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* aged ≥18 years;
* diagnosis of TMO was confirmed by X-ray interpreted by a radiologist;
* suffering from pain at the base of the thumb;
* the attending physician deems that an intra-articular corticosteroid injection would be beneficial, rather than opting for other types of intervention such as surgery
* can read, understand and answer in either French or English.

Exclusion Criteria:

* having received one or more corticosteroid injections in the last 3 months or surgery on the affected thumb;
* suffering from painful thumb caused by a trauma (e.g., fracture, sprain), rheumatoid arthritis, or De Quervain's tendonitis; and
* being pregnant or breastfeeding; and
* known allergies to any components of the solutions (triamcinolone acetonide, benzyl alcohol, carboxymethylcellulose sodium, hydrochloric acid, polysorbate, sodium chloride, or sodium hydroxide) or to iodinated contrast media.

Where it's running

  • Centre Hospitalier de l'Université de Montréal - Physiatry
    Montreal, Quebec, Canada
    Recruiting
  • Centre Hospitalier de l'Université de Montréal - Chirurgie plastique
    Montreal, Quebec, Canada
    Recruiting

Study contacts

  • Principal investigator: Tokiko Hamasaki, PhD — Université du Québec à Trois-Rivières
  • Study coordinator: Tokiko Hamasaki, PhD
  • Email: tokiko.hamasaki@uqtr.ca
  • Phone: 819-478-5011

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.